Microglial cannabinoid receptor type II stimulation improves cognitive impairment and neuroinflammation in Alzheimer’s disease mice by controlling astrocyte activation

Akira Sobue(Nagoya Industrial Science Research Institute), Koji Yamanaka(Nagoya University)
Cell Death and Disease
November 26, 2024
Cited by 27


Related Papers